Zhengzhou Pingzhi Culture Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Zhengzhou Pingzhi Culture Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include 7°NINOZURI. The owner is based in Henan Pilot Free Trade Zone.
No. 303, Unit 2, Building 6, Xiangsheng Community, No. 39 Xiangsheng Street, Zhengzhou Area (Zhengdong)
Henan Pilot Free Trade Zone 450000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhengzhou Pingzhi Culture Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Zhengzhou Pingzhi Culture Technology Co., Ltd. have?
Zhengzhou Pingzhi Culture Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Zhengzhou Pingzhi Culture Technology Co., Ltd. file in?
Zhengzhou Pingzhi Culture Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 31 (Natural Agricultural Products). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Zhengzhou Pingzhi Culture Technology Co., Ltd.'s most well-known trademarks?
Zhengzhou Pingzhi Culture Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as 7°NINOZURI. These are among 1 currently registered trademark in the portfolio.
What is Zhengzhou Pingzhi Culture Technology Co., Ltd.'s trademark registration success rate?
Zhengzhou Pingzhi Culture Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.